Lupin share price rose 2.5% after the company received USFDA approval for new drug to treat overactive bladder
Zee Business Video Team | Updated: September 30, 2022 02:56 PM IST
Lupin share price jumped nearly 2.5% to Rs 682 per share levels on the BSE intraday after the company received USFDA approval for Mirabegron Tablets or Generic Myrbetriq